Notably, G-CSF were widely administered (69.0 and 58.4% of patients in the preoperative and postoperative phase, respectively) in order to maintain dose intensity and this could partly explain (together with schedule modifications) the lower incidence of G 3–4 neutropenia compared with FLOT4. Here, CSF3 is linked to Decreased total neutrophil count.